An assessment study of known pyrazolopyrimidines: Chemical methodology and cellular activity
Authors:
- 1 June 2020
- journal article
- research article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 99, 103801
Abstract
No abstract availableKeywords
Funding Information
- Council of Scientific and Industrial Research, India
This publication has 107 references indexed in Scilit:
- Discovery of Potent and Selective Pyrazolopyrimidine Janus Kinase 2 InhibitorsJournal of Medicinal Chemistry, 2012
- Quantitative Preclinical Imaging of TSPO Expression in Glioma Using N,N-Diethyl-2-(2-(4-(2-18F-Fluoroethoxy)Phenyl)-5,7-Dimethylpyrazolo[1,5-a]Pyrimidin-3-yl)AcetamideJournal of Nuclear Medicine, 2012
- Targeting the MAPK–RAS–RAF signaling pathway in cancer therapyExpert Opinion on Therapeutic Targets, 2012
- Construction of a six-membered fused N-heterocyclic ring via a new 3-component reaction: synthesis of (pyrazolo)pyrimidines/pyridinesChemical Communications, 2011
- Design, Synthesis, Biological Activity, and ADME Properties of Pyrazolo[3,4-d]pyrimidines Active in Hypoxic Human Leukemia Cells: A Lead Optimization StudyJournal of Medicinal Chemistry, 2011
- Regulation of translocator protein 18kDa (TSPO) expression in health and disease states☆Molecular and Cellular Endocrinology, 2010
- Cell Signaling by Receptor Tyrosine KinasesCell, 2010
- Drugging the PI3 Kinome: From Chemical Tools to Drugs in the ClinicCancer Research, 2010
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI: Journal of the National Cancer Institute, 1990
- Peripheral benzodiazepine binding sites: Effect of PK 11195, 1-(2-chlorophenyl)-n-methyl-n-(1-methylpropyl)-3-isoquinolinecarboxamideLife Sciences, 1983